Illig R, Largo R H, Weber M, Augsburger T, Lipp A, Wissler D, Perrenoud A E, Torresani T
Acta Endocrinol Suppl (Copenh). 1986;279:346-53. doi: 10.1530/acta.0.112s346.
A prospective study of mental development has been carried out in 60 unselected children with congenital hypothyroidism (C.H.) detected between 1976 and February 1985. Treatment with 1-thyroxin was initiated at the age of 10.4 +/- 2.5 days and supervised by T4 and TSH monitoring in 3-6 monthly intervals. Although clinical signs were mild or missing, skeletal maturation was prenatal in more than half. Developmental testing was carried out at 1, 4 and 7 years by the Brunet-Lezine (n = 60), the non-verbal Snijders-Oomen (n = 40), and the german version of the Wechsler intelligence test (n = 20), respectively. The global DQ/IQ in all but a few children at each age group are within the 3rd and 97th percentile of the DQ/IQ distribution in a control group tested during the same period of time. The mean values of all global and subscores, however, are lower than that one in the control group, differences being highly significant at 1 year. In 21 of our 60 children, associated findings and/or risk factors were present. The DQ/IQ in children without risk factors are identical to that of the control group. There are no significant DQ/IQ differences neither between athyroidism and ectopic thyroid glands, nor between prenatal bone age and normal skeletal maturation at diagnosis. We assume that the favourable results in our children with C.H. may be ascribed to the early onset of thyroid hormone replacement and the strictly controlled compliance.
对1976年至1985年2月间检测出的60例未经挑选的先天性甲状腺功能减退症(C.H.)患儿进行了一项心理发育的前瞻性研究。在患儿10.4±2.5日龄时开始用左旋甲状腺素治疗,并通过每3至6个月监测一次T4和TSH进行监督。尽管临床症状轻微或缺失,但超过半数患儿的骨骼成熟情况处于产前阶段。分别在1岁、4岁和7岁时,采用布鲁内 - 勒津测试法(n = 60)、非言语斯尼德斯 - 奥门测试法(n = 40)以及韦氏智力测试德文版(n = 20)对患儿进行发育测试。除少数患儿外,各年龄组所有患儿的总体发育商数/智商均在同期测试的对照组发育商数/智商分布的第3百分位和第97百分位范围内。然而,所有总体及分项分数的平均值均低于对照组,在1岁时差异具有高度显著性。在我们的60例患儿中,有21例存在相关发现和/或危险因素。无危险因素患儿的发育商数/智商与对照组相同。甲状腺功能缺失症患儿与异位甲状腺患儿之间,以及诊断时产前骨龄与正常骨骼成熟情况之间,发育商数/智商均无显著差异。我们认为,我们的先天性甲状腺功能减退症患儿取得良好结果可能归因于甲状腺激素替代治疗的早期开始以及严格控制的依从性。